Fremanezumab to prevent period-related migraines
Treatments studied
Part of Brain & nervous system, Women’s health & pregnancy clinical trials.
This study tests whether the migraine prevention drug fremanezumab can reduce the number of migraines you get around your period. It is for women who have regular cycles and migraines that are clearly linked to their menstrual period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older who has not gone through menopause and has a regular menstrual cycle (21–32 days).
- You have been diagnosed with migraine (with or without aura) for at least a year and have at least 8 migraine days per month on average for the last 3 months.
- You experience at least 2 days of migraine related to your period per cycle, averaged over the last 3 months.
- You are willing to keep a daily headache diary for the entire study.
- You are not currently taking any other anti-CGRP migraine medication (like Aimovig, Emgality, or Ajovy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.
This trial tests whether a migraine medication (Fremanezumab) can help prevent acute mountain sickness when going to high altitude. If it works, it might make high-altitude trips safer and more comfortable for healthy people.
This program lets children and teens who finished a previous fremanezumab study keep receiving the medication. It is designed to provide continued treatment access under their doctor's supervision.
This study tests whether acupuncture can reduce the number of migraine headaches around your period. If you often get migraines with your menstrual cycle, this treatment might help prevent them.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
This study tests a CGRP-blocking antibody to see how it affects migraine symptoms and the body’s automatic (involuntary) nerve functions. It may help people with migraine who have already tried several preventive medicines.
Hear when a new Menstrual Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.